Skip to main content
Earnings Labs
Savara Inc. logo

Savara Inc. (SVRA)

NASDAQ·Healthcare·Biotechnology

$4.33

-7.19%

Mkt Cap $957.44M

Analyst Ratings

No recent rating data.

Price Target (12 analysts)

$10.00

Range $10.00 – $10.00

Implied Upside

+130.9%

Consensus $10.00 vs current $4.33